Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-19 · accession 0001808805-25-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-03-21 | 2025-03-19+ | NAUT | Patel Sujal M | CEO, Pres, Sec, Dir, 10% | P - Purchase | $0.9931 | +77.2K | 10.14M | +0.8% | +$76.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-19 | P | A | 53,300 | $0.99 | 10,117,788 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 53,300 shares purchased in the price range of $0.9469 to $1.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2025-03-20 | P | A | 23,933 | $1.00 | 10,141,721 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 23,933 shares purchased in the price range of $0.9351 to $1.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |